Hartoun Hartounian
Corporate Officer/Principal presso San Diego Tech Coast Angels
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Frank J. Creede | M | 66 |
San Diego Tech Coast Angels
| - |
Don W. Grimm | M | 82 |
San Diego Tech Coast Angels
| - |
William Carpenter | M | 72 |
San Diego Tech Coast Angels
| - |
Douglas F. Wall | M | - |
San Diego Tech Coast Angels
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Hugh Grant | M | 65 | 20 anni | |
Robert Shapiro | M | 85 | 7 anni | |
Joseph Himy | M | 53 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 7 anni |
Frank AtLee | M | 84 | 10 anni | |
James R. Gavin | M | 78 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | 5 anni |
Charles W. Burson | M | 79 | 5 anni | |
David T. DiGiacinto | M | 70 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 11 anni |
Eugene Bauer | M | 81 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 2 anni |
Richard de Schutter | M | 83 | 1 anni | |
William Parfet | M | 77 | 16 anni | |
Shirley Cunningham | F | 63 | 15 anni | |
Gerald Steiner | M | 63 | 13 anni | |
Gary Jacob | M | 77 | 1 anni | |
Duraiswami Narain | M | 60 | 20 anni | |
Joel Kanter | M | 67 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | - |
Charles Stephen McMillan | M | 77 | 18 anni | |
Carlos Popik | M | - | 5 anni | |
Yoshihiro Toyohara | M | - | 1 anni | |
Pierre Hochuli | M | 77 | 23 anni | |
James Neal | M | 68 | 2 anni | |
Lisa Harrell | F | - | 3 anni | |
Mark Andrew Iserloth | M | 61 | 4 anni | |
Jain Krotz | M | - |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | - |
Dagmar Meissner | F | - |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | - |
Steven Edward Meyer | M | 45 | 19 anni | |
Kevin A. Hainley | M | 67 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | 1 anni |
John L. Killmer | M | 74 | 2 anni | |
Sherri Brown | M | 63 | 19 anni | |
Rajendra D. Ketkar | M | 70 | 14 anni | |
Edward A. Steiger | M | 71 | 5 anni | |
Dennis Schemm | M | 58 | 12 anni | |
Steve Bierschenk | M | - | 18 anni | |
Jerry Steiner | M | - | 16 anni | |
Jay Byrne | M | - | 4 anni | |
Steven Hardardt | M | - | 3 anni | |
Barbara H. Wells | M | 68 | 17 anni | |
David W. Lobdell | M | - | 2 anni | |
Michael C. Snabes | M | 75 | 2 anni | |
Eric Fencl | M | 61 | 1 anni | |
Nathalie Joannes | F | - | 12 anni | |
Robert Reiter | M | - | - | |
Cameron Hall | M | - | 9 anni | |
Richard B. Clark | M | - | 8 anni | |
Vicki A. Gonzalez | F | - | 10 anni | |
John E. Burrows | M | 75 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 3 anni |
John J. Hagenbuch | M | 72 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | 2 anni |
Judith Reinsdorf | F | 60 | 5 anni | |
Ganesh Kishore | M | 70 | 20 anni | |
Gary Crittenden | M | 70 | 2 anni | |
Arnold Donald | M | 69 | 23 anni | |
Joan H. Walker | F | - | - | |
Bruce P. Bickner | M | 81 | 3 anni | |
John Murabito | M | 65 | 3 anni | |
Mark J. Leidy | M | 68 | - | |
Ian R. Miller | M | 73 | 3 anni | |
Kathryn E. Olson | F | 65 | 2 anni | |
Stephen R. Stetz | M | - | 35 anni | |
Robert A. Paley | M | 76 | - | |
Anik Bose | M | 62 | 4 anni | |
Donald F. Farley | M | 80 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 9 anni |
Arthur Lee Campbell | M | 73 | 20 anni | |
Susan Berland | F | 69 | 4 anni | |
Alastair Clemow | M | 72 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 1 anni |
Bradley A. Geier | M | - |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | 1 anni |
Amy Yoder | F | 56 | 6 anni | |
Andrew Last | M | 64 | 12 anni | |
Kevin P. Buchanan | M | 68 | 10 anni | |
Gary M. Banks | M | 73 | 6 anni | |
Juanita H. Hinshaw | F | 79 | - | |
Eugene Burleson | M | 83 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | - |
Robert W. Anderson | M | 86 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | - |
Barbara L. Blackford | F | 67 | 3 anni | |
Atul Dhir | M | - | 2 anni | |
William G. Kachioff | M | 58 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | 3 anni |
Steven T. Frankel | M | 81 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | - |
Patrick J. Fortune | M | 77 | 4 anni | |
David Cohen | M | 59 |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | 1 anni |
Cyndy Donato | M | - | 14 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 82 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Hartoun Hartounian
- Contatti personali